dc.contributor | Departament de Salut |
dc.contributor.author | Programa d'Harmonització Farmacoterapèutica |
dc.date.accessioned | 2019-06-17T06:45:04Z |
dc.date.available | 2019-06-17T06:45:04Z |
dc.date.issued | 2019-04-01 |
dc.identifier.citation | Programa d'Harmonització Farmacoterapèutica. Furoat de fluticasona/bromur d'umeclidini/vilanterol per al tractament de manteniment de la malaltia pulmonar obstructiva crònica. Barcelona: Servei Català de la Salut; 2019. |
dc.identifier.uri | https://hdl.handle.net/11351/4135 |
dc.description | Fluticasone furoate; Umeclidine bromide; Vilanterol; Chronic obstructive pulmonary disease |
dc.description.abstract | Furoat of fluticasone (FF) is a corticoid that increases the transcription of proteins
Anti-inflammatory, umeclidine bromide (UMEC) is a long-acting muscarinic antagonist (LAMA) that blocks the bronchoconstrictive action of acetylcholine in the smooth muscle cells of the respiratory tract and produces dilatation, and vilanterol (VI) is a LABA that causes bronchial smooth muscle relaxation by increasing levels of cyclic adenosine monophosphate (AMPcicllic): |
dc.language.iso | cat |
dc.publisher | Servei Català de la Salut |
dc.relation.ispartof | Programa d'Harmonització Farmacoterapèutica, Servei Català de la Salut |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Malalties obstructives - Tractament |
dc.subject | Fluticasona |
dc.subject.mesh | Pulmonary Disease, Chronic Obstructive |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Fluticasone |
dc.subject.mesh | /therapeutic use |
dc.subject.mesh | Drug Evaluation |
dc.title | Furoat de fluticasona/bromur d'umeclidini/vilanterol per al tractament de manteniment de la malaltia pulmonar obstructiva crònica |
dc.type | info:eu-repo/semantics/report |
dc.subject.decs | fluticasona |
dc.subject.decs | /uso terapéutico |
dc.subject.decs | enfermedad pulmonar obstructiva crónica |
dc.subject.decs | /tratamiento farmacológico |
dc.subject.decs | evaluación de medicamentos |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |